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Purpose or Objective  
Image guidance is a cornerstone in individualized and 
targeted radiotherapy. However, there is still a need to 
perform a comprehensive analysis of which lesions are 
visible in the images. Preliminary results and a method to 
correlate histopathology to in vivo PET/MRI of prostate 
cancer is presented. 
Material and Methods  
Full diagnostic in vivo PSMA-PET/MRI (3T SIGNA GE) was 
performed on 8 patients prior to robot assisted radical 
prostatectomy.   
Three-plane T2w MRIs were used to delineate prostate 
volumes. Individualized molds were created to preserve 
the in vivo shape and orientation of the prostate (fig. 1). 
All 3D-printed molds were created using a pre-created 
CAD model designed with 5 mm slits. The specimens were 
placed in their mold directly after each surgery. High 
resolution ex vivo T2w MRI of the fresh specimen was 
performed before formalin-fixation (within 90 minutes 
after the specimen left the patient´s body). The position 
of the MRI slices was localized according to the slits in 
the mold. The formalin-fixed specimen was sliced from 
the apex to base in 5 mm thick slices by the pathologist 
using the built-in slits in the mold. The standard 
procedure of PAD analysis was performed including 
paraffin embedding and microtoming in 5 µm thick slices. 
The histology slides were scanned with and without 
delineated Gleason score (GS), used to create GS specific 
maps. A 2D affine registration was used to register the 
histology to the ex vivo images on a slice by slice basis. 
The affine transform was used to account for specimen 
shrinkage during pathology preparations. The registered 
histology was then rigidly registered to the in vivo MRI 
using the ex vivo MRI as an intermediate.  
 
In each patient, all lesions were categorized depending 
on size (<5 cm or >5 cm) and Gleason score. A visual non-
blinded judgment of the lesion visibility using each 
imaging modality was performed. The judgement was 
done in consensus by two medical physicists, with the 
guidance of a radiologist.  
 
Results  
Our initial experience is that the procedure provides 
accurate mapping of pathological findings to in vivo 
PET/MRI data. GS maps can be co-registered to all 
included MRI sequences and PSMA PET. In the first 8 
patients, 83 lesions were detected by the pathologist, 
see table 1.   
 
Table 1: The number of lesions detected by the 
pathologist (histology) and the corresponding number of 
lesions detected in each imaging modality. 
Gleason score <5 mm 3+3 3+4 4+3 4+4 
Histology 41 8 10 0 
T2w 0 0 0 0 
ADC/DWI (b=1000 s/mm^2) 2 0 0 0 
Ktrans 0 0 0 0 
PSMA 1 1 1 0 
mpMRI+PSMA 2 1 1 0 
     
Gleason score >5 mm 3+3 3+4 4+3 4+4 
Histology 1 8 14 1 
T2w 0 5 4 0 
ADC/DWI (b=1000 s/mm^2) 1 3 8 1 
Ktrans 0 1 6 0 
PSMA 0 4 5 1 
mpMRI+PSMA 1 4 9 1 
Conclusion  
This is a time-efficient, non-expensive method in 
verifying image findings using histology. Our preliminary 
results suggest that combined PSMA-PET/mpMRI identifies 
more lesions than the individual imaging modalities.  
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Purpose or Objective  
Current clinical MRI techniques in rectal cancer are 
unable to differentiate Stage T1 from T2 (invasion of 
muscularis propria) tumours, and the differentiation of 
tumour from desmoplastic reaction or fibrous tissue 
remains a challenge1. Diffusion tensor imaging (DTI) MRI 
has potential to assess collagen structure and 
organisation (anisotropy). To our knowledge, there have 
been no MRI studies assessing DTI MRI for rectal cancer ex 
vivo. The purpose of this study was to examine DTI MRI 
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derived biomarkers of rectal cancer stromal 
heterogeneity at high field strength ex vivo.  
Material and Methods  
Ten rectal tissue specimens were collected from 5 
patients with a diagnosis of rectal cancer undergoing 
surgery through the Cancer Biobank. Two fresh specimens 
were collected from the surgical specimen of each 
patient: full thickness rectal cancer and full thickness 
adjacent normal rectum 5 – 10cm away from cancer. 
Tissue specimens were fixed in 10% formalin and 
embedded in 1% agarose containing 2mM gadopentetate 
dimeglumine for MR imaging. Tissue samples were 
scanned at 11.7 Tesla on the Bruker Avance II 500 MHz 
wide bore MRI. The MRI proctocol consisted of anatomical 
FLASH with 100 µm isotropic voxels, and functional DTI 
with 200 µm isotropic voxels and b-values 200, 800 and 
3200 s/mm2. Fractional Anisotropy (FA) values were 
calculated using the formula,  
 
where the λ1, λ2, λ3 and (λ) are the diffusion eigenvalues 
in three orthogonal directions and their average value, 
respectively. FA maps were generated with FA = 0 
indicating isotropic diffusion (no organisation). The 
specimens were examined by light microscopy using H&E 
and Masson Trichome stains. Regions of interest were 
annotated on digital histopathology with a Pathologist, 
for correlation with DTI MRI.  
Results  
Examination of colour-encoded DTI and FA maps and 
corresponding histopathology demonstrated low colour 
signal intensity and low FA values (range 0.14 – 0.16) in 
tumour regions, indicating a lack of anisotropy and lack 
of stromal organisation in cancer. Heterogeneity within 
cancer stroma was seen on the DTI maps, with regions of 
moderate colour signal intensity and moderate FA values 
corresponding to desmoplasia (range 0.25 – 0.40) or 
fibrous tissue (range 0.28 – 0.41). Cancer was able to be 
distinguished from normal muscularis propria which was 
clearly anisotropic on DTI maps with high signal intensity 
and high FA (range 0.58 – 0.70). Figure 1 shows that DTI 
was able to identify demosplasia (B) and also cancer 
invasion into muscularis propria (C).  
 
Conclusion  
This exploratory study demonstrated DTI-MRI to be a 
feasible method of differentiating cancer regions from 
desmoplasia and fibrous tissue ex vivo. DTI was also able 
to identify cancer invasion into muscularis propria. DTI 
may add value in more accurately defining tumour extent 
in rectal cancer, and warrants further investigation. 
1Beets-Tan et al Eur Radiol 2013:23:2522 
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Purpose or Objective  
Radiomics has shown a promise for predicting various 
endpoints in radiotherapy. So far radiomics-based models 
showed higher performance for endpoints referring 
directly to the primary tumor (local control) than for 
composite endpoints (loco-regional control and overall 
survival), which is potentially explained by most 
radiomics studies being based on the analysis of the 
primary tumor (PT) only. Here we hypothesize that loco-
regional control (LRC) can be better predicted by a 
combination of the PT and involved lymph nodes 
radiomics. 
Material and Methods  
Head and neck squamous cell carcinoma patients treated 
with definitive radiochemotherapy were included in this 
retrospective study (training n = 81, validation n = 52). 
Details on the studied cohorts are presented in Table 1. 
Radiomics analysis was performed on contrast-enhanced 
planning CT with an in-house developed radiomics 
implementation. 567 features were extracted from both 
PT and lymph nodes (LN). Only lymph nodes defined as 
macroscopically involved (based on the biopsy or PET 
imaging) were included in the analysis. Principal 
component (PC) analysis combined with univariable Cox 
regression was used for selection of non-redundant 
features. Radiomic features were grouped according to 
correlation with PC and per group, only the feature with 
the highest prognostic power (concordance index CI) was 
selected as an input to multivariable model.  The final 
model was trained using least absolute shrinkage and 
selection operator (100 times 10-fold cross validated). 
Two models for prediction of LRC were trained. The first 
model (PT model) was based only on the PT radiomic 
features. In the second model (mixed model), the PT 
radiomics was first linked to local tumor control (LC) and 
the predictions obtained from this model were used as an 
input to LRC model together with LN radiomics. The 
performance of the two models was compared in the 
validation cohort based on the CI, using the Wilcoxon test 
(p < 0.05) and the bootstrap method with 100 randomly 
selected samples to calculate the CI distribution. 
